A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

Worldwide, 350,000 women die from cervical cancer, the most common HPV cancer. “I think we can all agree that one dose and two doses of … these fantastic vaccines work really well,” said ...

HPV (human papillomavirus) is a common virus in the UK, and it is estimated that eight out of 10 people will be infected with HPV at some point in their lives. Chris Johnson, Head of the Vaccine ...

SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable strides in preventing cervical and oropharyngeal, or throat cancers.

Manipal Hospital Hebbal, in collaboration with Reach Lives, conducted an HPV vaccination drive for 70 underprivileged girls, offering the vaccine at no cost. Dr Shalini Sharma, Consultant ...

Dr. Howard Forman reflects on heartening new evidence for the effectiveness of the HPV vaccine—and troubling signs of vaccine ...

Physicians welcomed the vaccination program expansion, calling it ‘an extremely important step’ to tackle HPV, the most common sexually transmitted infection in the world. The National Program ...

The HPV vaccine can prevent cancers, including cervical cancer. It's recommended for girls between the ages nine and 45. Only about three in 10 eligible girls in Kenya received the human ...

In fact, it protects reproductive health by preventing HPV-related cancers. Myth 2: The HPV vaccine encourages promiscuity Some critics argue that vaccinating girls against a sexually transmitted ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next generation of KRAS inhibitors.

HPV is fuelling high cervical cancer rates in sub-Saharan Africa despite the availability of effective vaccines. Yet uptake remains low, driven largely by vaccine hesitancy. In South Africa alone, ...

The vaccine helps in building the fighting mechanism against certain types of HPV strains, with female aged between 9 to 25 years as the primary targeted group. The vaccine is recommended by the ...